Maxcyte (MXCT) Gross Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -7,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,111.00 |
| Dec 31, 2025 | -19,307.00 |
| Sep 30, 2025 | 24.00 |
| Jun 30, 2025 | -6,013.00 |
| Mar 31, 2025 | -2,314.00 |
| Dec 31, 2024 | -22,254.00 |
| Sep 30, 2024 | -9,712.00 |
| Jun 30, 2024 | 9,533.00 |
| Mar 31, 2024 | 2,537.00 |
| Dec 31, 2023 | 64,832.00 |
| Sep 30, 2023 | 4,385.00 |
| Jun 30, 2023 | -355.00 |
| Mar 31, 2023 | 6,179.00 |
| Dec 31, 2022 | 5,919.00 |
| Sep 30, 2022 | -3,429.00 |
| Jun 30, 2022 | -62.00 |
| Mar 31, 2022 | -4,604.00 |
| Dec 31, 2021 | -6,596.00 |
| Sep 30, 2021 | 3,485.00 |
| Jun 30, 2021 | -11,239.00 |